Literature DB >> 34411658

Effect of depression and suicidal behavior on neuropeptide Y (NPY) and its receptors in the adult human brain: A postmortem study.

Anuradha Sharma1, Xinguo Ren1, Hui Zhang1, Ghanshyam N Pandey2.   

Abstract

Neuropeptides are small proteinaceous molecules (3-100 amino acids) that are secreted by neurons and act on both neuronal and non-neuronal cells. Neuropeptide Y (NPY), a highly conserved and expressed neuropeptide in the central nervous system of mammals, plays a major role in stress response and resilience. Increasing evidence suggests that NPY and its receptors are altered in depression and suicide, pointing to their antidepressant-like nature. The objective of this study was to examine the role of NPY system in depression and suicidal behavior. Expression of NPY and its four receptors, NPY1R, NPY2R, NPY4R, and NPY5R was studied at the transcriptional and translational levels in the prefrontal cortex (PFC) and hippocampus regions of the postmortem brain of normal control (NC) (n = 24) and depressed suicide (DS) (n = 24) subjects. We observed a significant decrease in NPY mRNA and upregulation in NPY1R and NPY2R mRNA in both brain regions of DS subjects compared with NC subjects. We also observed a significant decrease in NPY protein expression in the PFC of subjects with DS. This study provides the first detailed evidence of alterations in the NPY system and the associated stress response in depression and suicidal behavior in humans. The outcomes of this study could be applied in the development of novel NPY system-targeted approaches for the treatment of depression.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Depression; Hippocampus; Neuropeptide Y; Prefrontal cortex; Suicide

Mesh:

Substances:

Year:  2021        PMID: 34411658      PMCID: PMC8489679          DOI: 10.1016/j.pnpbp.2021.110428

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  57 in total

1.  Neuropeptide Y (NPY) Y2 receptors mediate behaviour in two animal models of anxiety: evidence from Y2 receptor knockout mice.

Authors:  John P Redrobe; Yvan Dumont; Herbert Herzog; Rémi Quirion
Journal:  Behav Brain Res       Date:  2003-05-15       Impact factor: 3.332

2.  Quetiapine affects neuropeptide Y and corticotropin-releasing hormone in cerebrospinal fluid from schizophrenia patients: relationship to depression and anxiety symptoms and to treatment response.

Authors:  Georg Nikisch; Pierre Baumann; Tianmin Liu; Aleksander A Mathé
Journal:  Int J Neuropsychopharmacol       Date:  2011-10-19       Impact factor: 5.176

3.  Innate immunity in the postmortem brain of depressed and suicide subjects: Role of Toll-like receptors.

Authors:  Ghanshyam N Pandey; Hooriyah S Rizavi; Runa Bhaumik; Xinguo Ren
Journal:  Brain Behav Immun       Date:  2018-09-25       Impact factor: 7.217

4.  Antidepressant drugs increase the concentration of neuropeptide Y (NPY)-like immunoreactivity in the rat brain.

Authors:  M Heilig; C Wahlestedt; R Ekman; E Widerlöv
Journal:  Eur J Pharmacol       Date:  1988-03-15       Impact factor: 4.432

5.  Personalized prognostic prediction of treatment outcome for depressed patients in a naturalistic psychiatric hospital setting: A comparison of machine learning approaches.

Authors:  Christian A Webb; Zachary D Cohen; Courtney Beard; Marie Forgeard; Andrew D Peckham; Thröstur Björgvinsson
Journal:  J Consult Clin Psychol       Date:  2020-01

6.  Plasma neuropeptide Y in patients with major depressive disorder.

Authors:  H Hashimoto; H Onishi; S Koide; T Kai; S Yamagami
Journal:  Neurosci Lett       Date:  1996-09-20       Impact factor: 3.046

7.  Early life stress changes concentrations of neuropeptide Y and corticotropin-releasing hormone in adult rat brain. Lithium treatment modifies these changes.

Authors:  Henriette Husum; Aleksander A Mathé
Journal:  Neuropsychopharmacology       Date:  2002-11       Impact factor: 7.853

8.  CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder.

Authors:  Cailan Hou; Fujun Jia; Yi Liu; Lingjiang Li
Journal:  Brain Res       Date:  2006-05-19       Impact factor: 3.252

Review 9.  Corticotropin-releasing factor and neuropeptide Y: role in emotional integration.

Authors:  M Heilig; G F Koob; R Ekman; K T Britton
Journal:  Trends Neurosci       Date:  1994-02       Impact factor: 13.837

Review 10.  Neuropeptide Y: A stressful review.

Authors:  Florian Reichmann; Peter Holzer
Journal:  Neuropeptides       Date:  2015-09-30       Impact factor: 3.286

View more
  2 in total

1.  Salmon Calcitonin Exerts an Antidepressant Effect by Activating Amylin Receptors.

Authors:  Jian Jiang; Jun Ju; Liang Luo; Ze Song; Huanquan Liao; Xiuyan Yang; Shoupeng Wei; Dilong Wang; Wenhui Zhu; Jinlong Chang; Junzhe Ma; Hao Hu; Jiezhong Yu; Huiqing Wang; Sheng-Tao Hou; Shupeng Li; Huiliang Li; Ningning Li
Journal:  Front Pharmacol       Date:  2022-02-14       Impact factor: 5.810

Review 2.  Anxiety and Depression: What Do We Know of Neuropeptides?

Authors:  Ida Kupcova; Lubos Danisovic; Ivan Grgac; Stefan Harsanyi
Journal:  Behav Sci (Basel)       Date:  2022-07-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.